Literature DB >> 7694985

Bioavailability of medication delivered via nasogastric tube is decreased in the immediate postoperative period.

A B Elfant1, S M Levine, S R Peikin, B Cencora, L Méndez, M J Pello, U M Atabek, J B Alexander, R K Spence, R C Camishion.   

Abstract

BACKGROUND: A study was performed to determine bioavailability of medication delivered via nasogastric tube in patients after abdominal surgery.
METHODS: Acetaminophen (20 mg/kg) was administered to each patient per os at least 48 hours prior to abdominal surgery and via nasogastric tube 3 hours postoperatively. The nasogastric tube was clamped for 30 minutes after drug administration, prior to resuming suction. Serum levels of acetaminophen were measured 0, 40, and 90 minutes after each dose.
RESULTS: Acetaminophen levels were significantly lower (P < 0.001) when the drug was administered via nasogastric tube postoperatively.
CONCLUSIONS: Decreased bioavailability of medications delivered via nasogastric tube may have important clinical implications and should be taken into consideration during the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7694985     DOI: 10.1016/s0002-9610(99)80192-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Risks of interrupting drug treatment before surgery.

Authors:  D W Noble; H Kehlet
Journal:  BMJ       Date:  2000-09-23

Review 2.  Postoperative pain management in children and infants: an update.

Authors:  Christopher Brasher; Benjamin Gafsous; Sophie Dugue; Anne Thiollier; Joelle Kinderf; Yves Nivoche; Robert Grace; Souhayl Dahmani
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

3.  Interrupting drug therapy in the perioperative period.

Authors:  David W Noble; John Webster
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Reduced length of stay and hospitalization costs among inpatient hysterectomy patients with postoperative pain management including IV versus oral acetaminophen.

Authors:  Ryan N Hansen; An T Pham; Elaine A Boing; Belinda Lovelace; George J Wan; Richard D Urman
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.